Intuit Inc. - INTU

INTU Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
INTU	-0.5	-2.4	-10.9	-0.8	-8.3	0.7	12.3	113.6	591.1	22697.4
S&P 500	1.0	1.8	-0.9	2.7	7.3	26.5	31.0	80.1	196.5	33856.2

Compare INTU with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	INTU
name	Intuit Inc.
price	604.13
changes percentage	-0.52
change	-3.14
day low	596.20
day high	615.87
year high	714.78
year low	557.29
market cap	169106257210
price avg 50	648.17
price avg 200	631.97
exchange	NASDAQ
volume	2822722
avg volume	1592724
open	615
previous close	607.27
eps	10.26
pe	58.88
earnings announcement	2025-02-20T10:59:00.000+0000
shares outstanding	279917000
timestamp	2025-01-17 21:00:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 59.0%

Overall Quarterly Financial Health: 57.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000896878
revenue	16285000000	14368000000	13.34
gross profit	12820000000	11225000000	14.21
gross profit ratio	0.79	0.78	0.77
research and development expenses	2754000000	2539000000	8.47
operating expenses	9190000000	8084000000	13.68
interest income	147000000	96000000	53.12
interest expense	251000000	248000000	1.21
ebitda	4581000000	4043000000	13.31
ebitdaratio	0.28	0.28	-0.03
operating income	3630000000	3141000000	15.57
operating income ratio	0.22	0.22	1.96
net income	2963000000	2384000000	24.29
net income ratio	0.18	0.17	9.66
eps	10.58	8.48	24.76

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 16,285 million in 2024 from 14,368 million in 2023 representing a change of 13.34%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 12,820 million in 2024 from 11,225 million in 2023 representing a change of 14.21%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 2,754 million in 2024 from 2,539 million in 2023 representing a change of 8.47%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 4,581 million in 2024 from 4,043 million in 2023 representing a change of 13.31%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 3,630 million in 2024 from 3,141 million in 2023 representing a change of 15.57%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 2,963 million in 2024 from 2,384 million in 2023 representing a change of 24.29%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 10.58 in 2024 from 10.58 in 2023 representing a change of 24.76%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 9,190 million in 2024 from 8,084 million in 2023 representing a change of 13.68%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000896878
revenue	3283000000	3184000000	3.11
gross profit	2511000000	2401000000	4.58
gross profit ratio	0.76	0.75	1.43
research and development expenses	704000000	725000000	-2.90
operating expenses	2240000000	2887000000	-22.41
interest income	42000000	59000000	-28.81
interest expense	62000000	61000000	1.64
ebitda	271000000	128000000	111.72
ebitdaratio	0.08	0.04	105.33
operating income	271000000	-151000000	279.47
operating income ratio	0.08	-0.05	274.06
net income	197000000	-20000000	1,085.00
net income ratio	0.06	-0.01	1,055.30
eps	0.7	-0.07	1,080.39

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 3,283 million in 2025Q1 from 3,184 million in 2024Q4 representing a change of 3.11%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 2,511 million in 2025Q1 from 2,401 million in 2024Q4 representing a change of 4.58%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 2,240 million in 2025Q1 from 2,887 million in 2024Q4 representing a change of -22.41%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 271 million in 2025Q1 from 128 million in 2024Q4 representing a change of 111.72%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 271 million in 2025Q1 from -151 million in 2024Q4 representing a change of 279.47%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 197 million in 2025Q1 from -20 million in 2024Q4 representing a change of 1085.0%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.7 in 2025Q1 from 0.7 in 2024Q4 representing a change of 1080.39%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 704 million in 2025Q1 from 725 million in 2024Q4 representing a change of -2.9%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000896878
total assets	32132000000	27780000000	15.67
total liabilities	13696000000	10511000000	30.30
total equity	18436000000	17269000000	6.76
cash and cash equivalents	3609000000	2848000000	26.72
short term investments	465000000	814000000	-42.87
long term investments	131000000	105000000	24.76
total current assets	9678000000	5557000000	74.16
total non current assets	22454000000	22223000000	1.04
total current liabilities	7491000000	3790000000	97.65
total non current liabilities	6205000000	6721000000	-7.68
common stock	3000000	3000000	0.00
retained earnings	16989000000	15067000000	12.76
total debt	6567000000	6600000000	-0.50

Overall Score of Annual Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 32,132 million in 2024 from 27,780 million in 2023 representing a change of 15.67%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 18,436 million in 2024 from 17,269 million in 2023 representing a change of 6.76%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 3,609 million in 2024 from 2,848 million in 2023 representing a change of 26.72%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 9,678 million in 2024 from 5,557 million in 2023 representing a change of 74.16%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 16,989 million in 2024 from 15,067 million in 2023 representing a change of 12.76%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 6,567 million in 2024 from 6,600 million in 2023 representing a change of -0.5%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 13,696 million in 2024 from 10,511 million in 2023 representing a change of 30.3%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 465 million in 2024 from 814 million in 2023 representing a change of -42.87%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 7,491 million in 2024 from 3,790 million in 2023 representing a change of 97.65%. This indicates a higher short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000896878
total assets	33193000000	32132000000	3.30
total liabilities	15057000000	13696000000	9.94
total equity	18136000000	18436000000	-1.63
cash and cash equivalents	2872000000	3609000000	-20.42
short term investments	486000000	465000000	4.52
long term investments	90000000	131000000	-31.30
total current assets	10726000000	9678000000	10.83
total non current assets	22467000000	22454000000	0.06
total current liabilities	8619000000	7491000000	15.06
total non current liabilities	6438000000	6205000000	3.76
common stock	20619000000	3000000	687,200.00
retained earnings	16891000000	16989000000	-0.58
total debt	6937000000	6567000000	5.63

Overall Score of Quarterly Balance Sheet

0.4 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 33,193 million in 2025Q1 from 32,132 million in 2024Q4 representing a change of 3.3%. Suggesting a growth in asset holdings.

  Short Term Investments: Short Term Investments increased to 486 million in 2025Q1 from 465 million in 2024Q4 representing a change of 4.52%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 10,726 million in 2025Q1 from 9,678 million in 2024Q4 representing a change of 10.83%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 20,619 in 2025Q1 from 3 in 2024Q4 representing a change of 687200.0%. This indicates an increase in ownership interest.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 15,057 million in 2025Q1 from 13,696 million in 2024Q4 representing a change of 9.94%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 18,136 million in 2025Q1 from 18,436 million in 2024Q4 representing a change of -1.63%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 2,872 million in 2025Q1 from 3,609 million in 2024Q4 representing a change of -20.42%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 8,619 million in 2025Q1 from 7,491 million in 2024Q4 representing a change of 15.06%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 16,891 million in 2025Q1 from 16,989 million in 2024Q4 representing a change of -0.58%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 6,937 million in 2025Q1 from 6,567 million in 2024Q4 representing a change of 5.63%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000896878
net change in cash	4247000000	-145000000	3,028.97
operating cash flow	4884000000	5046000000	-3.21
free cash flow	4634000000	4786000000	-3.18
capital expenditure	-250000000	-260000000	3.85
depreciation and amortization	789000000	806000000	-2.11
deferred income tax	-554000000	-628000000	11.78
stock based compensation	1940000000	1712000000	13.32
accounts payables	133000000	-97000000	237.11
inventory	0	457000000	-100.00
acquisitions net	-83000000	-33000000	-151.52
investments in property plant and equipment	-191000000	-260000000	26.54
net cash used for investing activites	-227000000	-922000000	75.38
debt repayment	-89000000	-810000000	89.01
common stock issued	282000000	228000000	23.68
common stock repurchased	-1988000000	-1967000000	-1.07
dividends paid	-1034000000	-889000000	-16.31
net cash used provided by financing activities	-397000000	-4269000000	90.70
cash at end of period	7099000000	2852000000	148.91
accounts receivables	-100000000	42000000	-338.10
cash at beginning of period	2852000000	2997000000	-4.84

Overall Score of Annual Cashflow Statement

0.22 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 4,247 million in 2024 from -145 million in 2023 representing a change of 3028.97%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Accounts Receivables: Accounts Receivables decreased to -100 million in 2024 from 42 million in 2023 representing a change of -338.1%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 4,884 million in 2024 from 5,046 million in 2023 representing a change of -3.21%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 4,634 million in 2024 from 4,786 million in 2023 representing a change of -3.18%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -250 million in 2024 from -260 million in 2023 representing a change of 3.85%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to -554 million in 2024 from -628 million in 2023 representing a change of 11.78%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 1,940 million in 2024 from 1,712 million in 2023 representing a change of 13.32%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 133 million in 2024 from 97 million in 2023 representing a change of 237.11%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -1,034 million in 2024 from -889 million in 2023 representing a change of -16.31%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000896878
operating cash flow	362000000	417000000	-13.19
free cash flow	329000000	375000000	-12.27
capital expenditure	-33000000	-42000000	21.43
depreciation and amortization	201000000	208000000	-3.37
deferred income tax	-91000000	-193000000	52.85
stock based compensation	511000000	519000000	-1.54
accounts receivables	82000000	259000000	-68.34
accounts payables	-75000000	-153000000	50.98
inventory	0	0	NaN
acquisitions net	0	-83000000	100.00
investments in property plant and equipment	-33000000	17000000	-294.12
net cash used for investing activites	-188000000	-252000000	25.40
debt repayment	85000000	85000000	0.00
common stock issued	0	0	NaN
common stock repurchased	-557000000	-281000000	-98.22
dividends paid	-296000000	-261000000	-13.41
net cash used provided by financing activities	761000000	454000000	67.62
net change in cash	935000000	-606000000	254.29
cash at end of period	8034000000	3609000000	122.61
cash at beginning of period	7099000000	4215000000	68.42

Overall Score of Quarterly Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 935 million in 2025Q1 from -606 million in 2024Q4 representing a change of 254.29%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Stock-Based Compensation: Stock-Based Compensation decreased to 511 million in 2025Q1 from 519 million in 2024Q4 representing a change of -1.54%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 75 million in 2025Q1 from 153 million in 2024Q4 representing a change of 50.98%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to 82 million in 2025Q1 from 259 million in 2024Q4 representing a change of -68.34%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 362 million in 2025Q1 from 417 million in 2024Q4 representing a change of -13.19%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 329 million in 2025Q1 from 375 million in 2024Q4 representing a change of -12.27%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -33 million in 2025Q1 from -42 million in 2024Q4 representing a change of 21.43%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to -91 million in 2025Q1 from -193 million in 2024Q4 representing a change of 52.85%. This indicates that the company's tax liability for future periods has increased.

  Dividends Paid: Dividends Paid decreased to -296 million in 2025Q1 from -261 million in 2024Q4 representing a change of -13.41%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q1 2025 Earnings call transcript
Q4 2024 Earnings call transcript
Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-07-31	2023-07-31	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	58.16	51.13	13.75
net income per share	10.58	8.48	24.73
operating cash flow per share	17.44	17.96	-2.86
free cash flow per share	16.55	17.03	-2.83
cash per share	14.55	13.03	11.65
book value per share	65.84	61.46	7.14
tangible book value per share	-4.39	-10.43	57.94
shareholders equity per share	65.84	61.46	7.14
interest debt per share	24.35	24.37	-0.08
market cap	181258000000	143787700000	26.06
enterprise value	184216000000	147539700000	24.86
pe ratio	61.17	60.31	1.43
price to sales ratio	11.13	10.01	11.22
pocfratio	37.11	28.5	30.24
pfcf ratio	39.11	30.04	30.19
pb ratio	9.83	8.33	18.08
ptb ratio	9.83	8.33	18.08
ev to sales	11.31	10.27	10.16
enterprise value over ebitda	40.21	36.49	10.20
ev to operating cash flow	37.72	29.24	29.00
ev to free cash flow	39.75	30.83	28.95
earnings yield	0.02	0.02	-1.41
free cash flow yield	0.03	0.03	-23.19
debt to equity	0.36	0.38	-6.80
debt to assets	0.2	0.24	-13.98
net debt to ebitda	0.65	0.93	-30.42
current ratio	1.29	1.47	-11.89
interest coverage	14.46	12.67	14.19
income quality	1.65	2.12	-22.12
dividend yield	0.01	0.01	-7.73
payout ratio	0.35	0.37	-6.42
sales general and administrative to revenue	0.09	0.12	-27.64
research and ddevelopement to revenue	0.17	0.18	-4.30
intangibles to total assets	0.61	0.73	-15.83
capex to operating cash flow	0.05	0.05	-0.66
capex to revenue	0.02	0.02	-15.16
capex to depreciation	0.32	0.32	-1.77
stock based compensation to revenue	0.12	0.12	-0.02
graham number	125.21	108.31	15.60
roic	0.12	0.1	15.51
return on tangible assets	0.24	0.31	-24.43
graham net net	-30.84	-20.63	-49.44
working capital	2187000000	1767000000	23.77
tangible asset value	-1228000000	-2930000000	58.09
net current asset value	-4018000000	-4954000000	18.89
invested capital	23271000000	23404000000	-0.57
average receivables	1219000000	1084500000	12.40
average payables	679500000	687500000	-1.16
average inventory	210000000	210000000	0.00
days sales outstanding	29.52	28.48	3.65
days payables outstanding	75.95	74.09	2.51
days of inventory on hand	0	48.78	-100.00
receivables turnover	12.37	12.82	-3.53
payables turnover	4.81	4.93	-2.45
inventory turnover	0	7.48	-100.00
roe	0.16	0.14	16.42
capex per share	0.89	0.93	-3.50

• Positive

  ROE: Return on Equity (ROE) increased to 0.16 on 2024-07-31 from 0.14 on 2023-07-31, representing a change of 16.42%. Suggesting the company has been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 61.17 on 2024-07-31 from 60.31 on 2023-07-31, representing a change of 1.43%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.36 on 2024-07-31 from 0.38 on 2023-07-31, representing a change of -6.80%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.29 on 2024-07-31 from 1.47 on 2023-07-31, representing a change of -11.89%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-10-31 Q1	2024-07-31 Q4	Q/Q change %
INTU
calendar year	2025	2024	NaN
revenue per share	11.72	11.37	3.11
net income per share	0.7	-0.07	1,085.00
operating cash flow per share	1.29	1.49	-13.19
free cash flow per share	1.18	1.34	-12.27
cash per share	11.99	14.55	-17.57
book value per share	64.77	65.84	-1.63
tangible book value per share	-4.89	-4.39	-11.56
shareholders equity per share	64.77	65.84	-1.63
interest debt per share	25.0	23.67	5.60
market cap	170884000000	181258000000	-5.72
enterprise value	174949000000	184216000000	-5.03
pe ratio	216.86	-2265.73	109.57
price to sales ratio	52.05	56.93	-8.57
pocfratio	472.06	434.67	8.60
pfcf ratio	519.4	483.35	7.46
pb ratio	9.42	9.83	-4.16
ptb ratio	9.42	9.83	-4.16
ev to sales	53.29	57.86	-7.89
enterprise value over ebitda	645.57	1439.19	-55.14
ev to operating cash flow	483.28	441.76	9.40
ev to free cash flow	531.76	491.24	8.25
earnings yield	0.0	-0.0	1,144.80
free cash flow yield	0.0	0.0	-6.94
debt to equity	0.38	0.36	7.38
debt to assets	0.21	0.2	2.26
net debt to ebitda	15	23.11	-35.09
current ratio	1.24	1.29	-3.68
interest coverage	4.37	-2.48	276.58
income quality	1.84	-20.85	108.81
dividend yield	0.0	0.0	20.29
payout ratio	1.5	-13.05	111.51
sales general and administrative to revenue	0.12	0.12	1.36
research and ddevelopement to revenue	0.21	0.23	-5.82
intangibles to total assets	0.59	0.61	-3.97
capex to operating cash flow	0.09	0.1	-9.49
capex to revenue	0.01	0.01	-23.80
capex to depreciation	0.16	0.2	-18.69
stock based compensation to revenue	0.16	0.16	-4.51
graham number	32.02	10.29	211.28
roic	0.01	-0.0	1,268.32
return on tangible assets	0.01	-0.0	997.27
graham net net	-38.18	-30.84	-23.81
working capital	2107000000	2187000000	-3.66
tangible asset value	-1370000000	-1228000000	-11.56
net current asset value	-4331000000	-4018000000	-7.79
invested capital	23159000000	23271000000	-0.48
average receivables	1331000000	1408000000	-5.47
average payables	686500000	803500000	-14.56
average inventory	0	0	NaN
days sales outstanding	36.87	37.23	-0.95
days payables outstanding	76.01	82.87	-8.28
days of inventory on hand	0	0	NaN
receivables turnover	2.44	2.42	0.96
payables turnover	1.18	1.09	9.03
inventory turnover	0	0	NaN
roe	0.01	-0.0	1,101.29
capex per share	0.12	0.15	-21.43

• Negative

  ROE: Return on Equity (ROE) increased to 0.01 on 2024-10-31 Q1 from -0.00 on 2024-07-31 Q4, representing a change of 1101.29%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 216.86 on 2024-10-31 Q1 from -2265.73 on 2024-07-31 Q4, representing a change of 109.57%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.24 on 2024-10-31 Q1 from 1.29 on 2024-07-31 Q4, representing a change of -3.68%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.38 on 2024-10-31 Q1 from 0.36 on 2024-07-31 Q4, representing a change of 7.38%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 591.78 which is lower than current price 604.13, indicates the company may be overvalued.